International survey supports early initiation of enzyme replacement in Fabry disease

Later enzyme replacement therapy initiation leads to higher annual rates of renal and cardiac deterioration.
Later enzyme replacement therapy initiation leads to higher annual rates of renal and cardiac deterioration.